Schedule 13G ownership disclosure
FOAMIX PHARMACEUTICALS LTD
Security class unavailable · CUSIP: M46135105
Event date: 2017-04-10
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 12.8700%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000930413-17-002066
- Form type
- SC 13G
- Filer
- Foamix Pharmaceuticals Ltd.
- CIK
- CIK 1606645
- Filed
- May 10, 2017
- Reporting period
- Apr 10, 2017
- Description
- Schedule 13G beneficial ownership